Article Versions Notes

Solana JC, Ramírez L, Cook EC, Hernández-García E, Sacristán S, Martín ME, Manuel González V, Reguera RM, Balaña-Fouce R, Fresno M, et al. Subcutaneous Immunization of Leishmania HSP70-II Null Mutant Line Reduces the Severity of the Experimental Visceral Leishmaniasis in BALB/c Mice. Vaccines. 2020; 8(1):141. https://doi.org/10.3390/vaccines8010141

Solana, José Carlos, Laura Ramírez, Emma CL Cook, Elena Hernández-García, Silvia Sacristán, M. Elena Martín, Víctor Manuel González, Rosa María Reguera, Rafael Balaña-Fouce, Manuel Fresno, and et al. 2020. "Subcutaneous Immunization of Leishmania HSP70-II Null Mutant Line Reduces the Severity of the Experimental Visceral Leishmaniasis in BALB/c Mice" Vaccines 8, no. 1: 141. https://doi.org/10.3390/vaccines8010141

Solana, J. C., Ramírez, L., Cook, E. C., Hernández-García, E., Sacristán, S., Martín, M. E., Manuel González, V., Reguera, R. M., Balaña-Fouce, R., Fresno, M., Requena, J. M., Iborra, S., & Soto, M. (2020). Subcutaneous Immunization of Leishmania HSP70-II Null Mutant Line Reduces the Severity of the Experimental Visceral Leishmaniasis in BALB/c Mice. Vaccines, 8(1), 141. https://doi.org/10.3390/vaccines8010141